18 May 2013
Keywords: positive, ph, iii, data, cancer, drug, ptk/zk
Article | 28 March 2005
German drugmaker Schering AG and Swiss pharmaceutical major Novartis say that positive results from a Phase III trial of PTK/ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 March 2005
4 April 2005
17 May 2013
© 2013 thepharmaletter.com